Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab
Author:
Funder
Research to Prevent Blindness
National Eye Institute
Alcon Research Institute
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/159125/files/pdf
Reference42 articles.
1. Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti–VEGF Drug Type for 1 Year in the IRIS Registry
2. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
3. Aflibercept for neovascular age-related macular degeneration;Sarwar;Cochrane Database Syst Rev,2016
4. Intravitreal Bevacizumab and Aflibercept for the Treatment of Exudative Age-Related Macular Degeneration
5. The burden of neovascular age-related macular degeneration: a patient’s perspective
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Trends in Anti-Vascular Endothelial Growth Factor Original Medicare Part B Claims in the United States, 2014–2019;Ophthalmic Epidemiology;2024-02-05
2. Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy;Theranostics;2024
3. Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration;Indian Journal of Ophthalmology;2023-12-22
4. Pathologic vs. protective roles of hypoxia-inducible factor 1 in RPE and photoreceptors in wet vs. dry age-related macular degeneration;Proceedings of the National Academy of Sciences;2023-12-06
5. Detection and diagnosis of age-related macular degeneration using recurrent neural network with cloud architecture and internet of things;Journal of Intelligent & Fuzzy Systems;2023-12-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3